Baldacchino, ShawnWastall, Laura MSaliba, ChristianHughes, Thomas AScerri, ChristianBerwick, AngeleneSpeirs, ValerieHanby, Andrew MGrech, Godfrey2018-07-202018-07-202017-10Baldacchino, S, Wastall, L M, Saliba, C, Hughes, T A, Scerri, C, Berwick, A, Speirs, V, Hanby, A M & Grech, G 2017, 'CIP2A expression predicts recurrences of tamoxifen-treated breast cancer', Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 39, no. 10, pp. 1010428317722064. https://doi.org/10.1177/10104283177220641010-4283ORCID: /0000-0002-0602-4666/work/72631344http://hdl.handle.net/2164/10762539474engSDG 3 - Good Health and Well-beingAutoantigensBreast NeoplasmsDisease-Free SurvivalFemaleHumansImmunohistochemistryMembrane ProteinsNeoplasm Recurrence, LocalPrognosisReceptors, EstrogenTamoxifenJournal ArticleR MedicineRJournal article10.1177/10104283177220643910